Navigation Links
Psychiatrists, parents significantly differ in ADHD, psychiatric comorbidities perceptions
Date:10/25/2007

Orlando, FL - October 25, 2007- According to a small-scale, in-office, observational study, psychiatrists and parents have significantly different perceptions of the importance of pediatric ADHD and psychiatric comorbidities, particularly regarding the patients most concerning behavior. The study, which utilized accepted sociolinguistic methodologies to evaluate the tone, content and structure of in-office visits, was presented recently at the 20th annual U.S. Psychiatric and Mental Health Congress (USPMHC).

We found that among the psychiatrists and parents studied, 78 percent provided different responses when asked about the patients most concerning behavior, said Robert Findling, M.D., lead author and professor of psychiatry at Case Western Reserve University and director of the division of child and adolescent psychiatry at University Hospitals Case Medical Center. There was a notable incidence of psychiatrist/parent misalignment regarding the patients most concerning behaviors, including aggression and defiance.

The study, designed to capture naturally occurring conversations between psychiatrists, patients with ADHD and their parents, consisted of eleven psychiatrists, thirty-two child and adolescent ADHD patients and their parents. Half of the patients were younger than 13 years old, and the majority fulfilled the criteria of complicated ADHD, which was defined in the study as a patient having or suspected to have one or more psychiatric comorbidities. Physicians classified 81 percent of patients as having one or more psychiatric comorbidities/learning disabilities. The most common comorbidities greater than 20 percent included: depression (46 percent), oppositional defiant disorder (42 percent), anxiety (38 percent), learning disabilities (35 percent) and bipolar disorder (23 percent). In post-visit interviews, parents most often reported concern about aggression and defiance; however, these behaviors that parents reported as mo
'/>"/>

Contact: Sherry Goldberg
212-601-8279
Porter Novelli
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Children suffer the most when parents divorce
2. Teens listen to parents about smoking
3. Smoking may be influenced by Parents
4. Few Parents Help Kids Fight Acne
5. Parents Should Look For Signs Of Children Becoming Overweight
6. HIV-positive Parents Require More Counseling
7. Parents understand better the hearing loss problem in children if counseled
8. Teaching parents to deal with behavior problems in children
9. Parents Should Beware of Violent Video Games
10. Risk Of Pre-eclampsia May Be In The Genes Of The Parents.
11. Pediatricians Need To Talk To Parents Of Overweight Kids
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Daniel K. Spiegelman Elected to Board of Directors of Omeros 2Drug Candidates in Pipeline Offer Potential for Parkinson's Disease Therapeutics Market, Says Frost & Sullivan 2Drug Candidates in Pipeline Offer Potential for Parkinson's Disease Therapeutics Market, Says Frost & Sullivan 3Reportlinker Adds Medical Fiber Optics - A World Market Analysis 2Reportlinker Adds Medical Fiber Optics - A World Market Analysis 3Reportlinker Adds Medical Fiber Optics - A World Market Analysis 4Reportlinker Adds Medical Fiber Optics - A World Market Analysis 5Reportlinker Adds Medical Fiber Optics - A World Market Analysis 6Navigating in the ocean of molecules 9514 1Navigating in the ocean of molecules 9514 2Navigating in the ocean of molecules 9514 3NIH stimulus funding supports Emory biomedical scientists 9512 1NIH stimulus funding supports Emory biomedical scientists 9512 2NIH stimulus funding supports Emory biomedical scientists 9512 3NIH stimulus funding supports Emory biomedical scientists 9512 4Midwest Medical Aesthetics Helps Defy Nature and Wrinkles with Artefill 53946 1Midwest Medical Aesthetics Helps Defy Nature and Wrinkles with Artefill 53946 2Midwest Medical Aesthetics Helps Defy Nature and Wrinkles with Artefill 53946 3
Other Medicine Technology:Poniard Pharmaceuticals Completes Enrollment of Phase 2 Picoplatin Trial in Colorectal Cancer 2Poniard Pharmaceuticals Completes Enrollment of Phase 2 Picoplatin Trial in Colorectal Cancer 3Poniard Pharmaceuticals Completes Enrollment of Phase 2 Picoplatin Trial in Colorectal Cancer 4Data Presented at the American Psychiatric Association (APA) Annual Meeting Demonstrate Iloperidone's Efficacy and Safety, With Low Rates of Movement and Metabolic Adverse Events 2Data Presented at the American Psychiatric Association (APA) Annual Meeting Demonstrate Iloperidone's Efficacy and Safety, With Low Rates of Movement and Metabolic Adverse Events 3Data Presented at the American Psychiatric Association (APA) Annual Meeting Demonstrate Iloperidone's Efficacy and Safety, With Low Rates of Movement and Metabolic Adverse Events 4Data Presented at the American Psychiatric Association (APA) Annual Meeting Demonstrate Iloperidone's Efficacy and Safety, With Low Rates of Movement and Metabolic Adverse Events 5Data Presented at the American Psychiatric Association (APA) Annual Meeting Demonstrate Iloperidone's Efficacy and Safety, With Low Rates of Movement and Metabolic Adverse Events 6Data Presented at the American Psychiatric Association (APA) Annual Meeting Demonstrate Iloperidone's Efficacy and Safety, With Low Rates of Movement and Metabolic Adverse Events 7